A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy
Introduction Oligometastatic prostate cancer can be well‐controlled through combined local and metastasis‐directed therapies. However, the effects of cytoreductive radical prostatectomy and metastasectomy remain unclear. Case presentation A 52‐year‐old man presented with prostate cancer and isolated...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-03-01
|
| Series: | IJU Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iju5.12693 |
| _version_ | 1797280244747468800 |
|---|---|
| author | Daisuke Mamiya Toshiki Kijima Atsuko Takada‐Owada Hidetoshi Kokubun Toshitaka Uematsu Kohei Takei Tsunehito Kambara Kazuyuki Ishida Hiroshi Taneichi Takao Kamai |
| author_facet | Daisuke Mamiya Toshiki Kijima Atsuko Takada‐Owada Hidetoshi Kokubun Toshitaka Uematsu Kohei Takei Tsunehito Kambara Kazuyuki Ishida Hiroshi Taneichi Takao Kamai |
| author_sort | Daisuke Mamiya |
| collection | DOAJ |
| description | Introduction Oligometastatic prostate cancer can be well‐controlled through combined local and metastasis‐directed therapies. However, the effects of cytoreductive radical prostatectomy and metastasectomy remain unclear. Case presentation A 52‐year‐old man presented with prostate cancer and isolated bone metastasis to the thoracic spine. Six months after neoadjuvant hormonal therapy, the patient underwent cytoreductive radical prostatectomy and total en bloc spondylectomy. The postoperative course was uneventful. Hormonal therapy was terminated 5 years after surgery, and no biochemical or radiological progression was observed at 7 years postoperatively. Conclusion Although careful patient selection is necessary, cytoreductive radical prostatectomy and metastasectomy are effective treatments for well‐selected patients with oligometastatic prostate cancer. |
| first_indexed | 2024-03-07T16:37:24Z |
| format | Article |
| id | doaj.art-6429417e57c247609addffa8a20c2a04 |
| institution | Directory Open Access Journal |
| issn | 2577-171X |
| language | English |
| last_indexed | 2024-03-07T16:37:24Z |
| publishDate | 2024-03-01 |
| publisher | Wiley |
| record_format | Article |
| series | IJU Case Reports |
| spelling | doaj.art-6429417e57c247609addffa8a20c2a042024-03-03T09:26:39ZengWileyIJU Case Reports2577-171X2024-03-017216516810.1002/iju5.12693A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomyDaisuke Mamiya0Toshiki Kijima1Atsuko Takada‐Owada2Hidetoshi Kokubun3Toshitaka Uematsu4Kohei Takei5Tsunehito Kambara6Kazuyuki Ishida7Hiroshi Taneichi8Takao Kamai9Department of Urology Dokkyo Medical University Shimotsuga Tochigi JapanDepartment of Urology Dokkyo Medical University Shimotsuga Tochigi JapanDepartment of Diagnostic Pathology Dokkyo Medical University Shimotsuga Tochigi JapanDepartment of Urology Dokkyo Medical University Shimotsuga Tochigi JapanDepartment of Urology Dokkyo Medical University Shimotsuga Tochigi JapanDepartment of Urology Dokkyo Medical University Shimotsuga Tochigi JapanDepartment of Urology Nasu Red Cross Hospital Otawara Tochigi JapanDepartment of Diagnostic Pathology Dokkyo Medical University Shimotsuga Tochigi JapanDepartment of Orthopaedic Surgery Dokkyo Medical University Shimotsuga Tochigi JapanDepartment of Urology Dokkyo Medical University Shimotsuga Tochigi JapanIntroduction Oligometastatic prostate cancer can be well‐controlled through combined local and metastasis‐directed therapies. However, the effects of cytoreductive radical prostatectomy and metastasectomy remain unclear. Case presentation A 52‐year‐old man presented with prostate cancer and isolated bone metastasis to the thoracic spine. Six months after neoadjuvant hormonal therapy, the patient underwent cytoreductive radical prostatectomy and total en bloc spondylectomy. The postoperative course was uneventful. Hormonal therapy was terminated 5 years after surgery, and no biochemical or radiological progression was observed at 7 years postoperatively. Conclusion Although careful patient selection is necessary, cytoreductive radical prostatectomy and metastasectomy are effective treatments for well‐selected patients with oligometastatic prostate cancer.https://doi.org/10.1002/iju5.12693cytoreductive surgerymetastasectomyoligometastasisprogression‐free survivalprostate cancer |
| spellingShingle | Daisuke Mamiya Toshiki Kijima Atsuko Takada‐Owada Hidetoshi Kokubun Toshitaka Uematsu Kohei Takei Tsunehito Kambara Kazuyuki Ishida Hiroshi Taneichi Takao Kamai A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy IJU Case Reports cytoreductive surgery metastasectomy oligometastasis progression‐free survival prostate cancer |
| title | A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy |
| title_full | A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy |
| title_fullStr | A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy |
| title_full_unstemmed | A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy |
| title_short | A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy |
| title_sort | patient with oligometastatic hormone sensitive prostate cancer who achieved long term progression free survival following cytoreductive radical prostatectomy and metastasectomy |
| topic | cytoreductive surgery metastasectomy oligometastasis progression‐free survival prostate cancer |
| url | https://doi.org/10.1002/iju5.12693 |
| work_keys_str_mv | AT daisukemamiya apatientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT toshikikijima apatientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT atsukotakadaowada apatientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT hidetoshikokubun apatientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT toshitakauematsu apatientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT koheitakei apatientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT tsunehitokambara apatientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT kazuyukiishida apatientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT hiroshitaneichi apatientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT takaokamai apatientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT daisukemamiya patientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT toshikikijima patientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT atsukotakadaowada patientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT hidetoshikokubun patientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT toshitakauematsu patientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT koheitakei patientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT tsunehitokambara patientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT kazuyukiishida patientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT hiroshitaneichi patientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy AT takaokamai patientwitholigometastatichormonesensitiveprostatecancerwhoachievedlongtermprogressionfreesurvivalfollowingcytoreductiveradicalprostatectomyandmetastasectomy |